Pets at Home Group Plc: FY24 Interim Results
for the 28-week period to 12 October 2023
Resilient performance through key period of strategic execution; full year guidance maintained
Pets at Home Group Plc is pleased to report its FY24 Interim Results for the 28-week period to 12 October 2023. The report is available at http://www.rns-pdf.londonstockexchange.com/rns/8256U_1-2023-11-27.pdf and on the corporate website www.petsathomeplc.com/investors.
Results webcast
An audio webcast and presentation of these results will be available on our website (https://investors.petsathome.com/) from 07.00am on 28 November. Management will host a Q&A conference call for analysts and investors at 09.30am. To join the call in listen-only mode, please click on the following link (https://brrmedia.news/PETS_FY24IR). Those wishing to participate in the Q&A session should email pets@accordience.com for call details.
Our next scheduled update will be our Q3 FY24 release on 30 January 2024.
Investor Relations Enquiries
|
Pets at Home Group Plc: |
|
|
Andrew Porteous, Director of Investor Relations |
+44 (0) 7740 361 849 |
|
Chris Ridgway, Head of Investor Relations |
+44 (0) 7788 783 925 |
Media Enquiries
|
Pets at Home Group Plc: |
|
|
Natalie Cullington, Head of Communications |
+44 (0) 7974 594 701 |
|
Citigate Dewe Rogerson: |
|
|
Angharad Couch |
+44 (0) 7507 643 004 |
About Pets at Home
Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 440 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: http://investors.petsathome.com/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
